KPTI Prakiraan wutah bathi resik saben saham kanggo taun ngarep Karyopharm Therapeutics Inc.

Logo korporat perusahaan Karyopharm Therapeutics (KPTI)

Analysts' assessments of net profit dynamics for n+1 demonstrate a sales scaling strategy and the pursuit of new niches, while 0.00 records a new level mark for Karyopharm Therapeutics (KPTI). Revenue growth is based on Xpovio sales, the expansion of cancer therapies, and royalties. Supply stability is ensured by strict temperature-controlled logistics, guaranteeing drug quality for patients.

KPTI: Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Karyopharm Therapeutics, Inc. 04.07.2022 - 18.11.2026

Rincian metrik keuangan lan pasar Karyopharm Therapeutics, Inc. (KPTI)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:Karyopharm, KPTI
Produk merek Karyopharm Therapeutics Inc.

The stability of the clinical base of Karyopharm Therapeutics (KPTI) in the US and EU minimizes external risks, creating a foundation for revenue forecasting. This metric measures the expected percentage growth in net income per share, reflecting the analysts' consensus forecast for future business profitability. The consolidation of the projected earnings per share change for the coming year signals a pause in asset revaluation, requiring investors to exercise caution when entering a position.

Perusahaan pesaing

GMAB (Genmab Corp) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep exelixis.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nuvalent (NUVL)|KYMR (Kymera) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep IDYA (IDEAYA Biosciences Inc)|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Enliven Pharma|ORIC Pharmaceuticals Inc - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Relay Therapeutics, Inc.|NRIX (Nurix Therapeutics) - Prakiraan wutah bathi saben saham kanggo taun ngarep|TYRA: Proyeksi tambahing bathi saben saham ing taun ngarep|VSTM (verastem.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Monte Rosa Tx GLUE|Prakiraan wutah bathi kanggo taun ngarep CGEM|Immuneering - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|C4 Therapeutics - Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep BDTX|RPTX: Prakiraan wutah bathi saben saham kanggo taun ngarep|PMV Pharma - Proyeksi tambahing bathi saben saham ing taun ngarep|PPCB: Prakiraan wutah bathi kanggo taun ngarep|Bio Green Med Solution Inc - Dinamika bathi saben saham sing diarepake ing taun ngarep|AADI (Aadi Bioscience Inc) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep aileronrx.com ALRN|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Blueprint Medicines Corp. (BPMC)|GLYC (GlycoMimetics) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SWTX (SpringWorks Therapeutics, Inc)